跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,129 条关于
“DEBRA Piel Mariposa”
全部
1,129
临床试验
904
药物
31
机构
9
资讯
185
去年
Repurposing Losartan: Hypertension Drug Shows Promise for Treating Epidermolysis Bullosa in Children
去年
CureDuchenne Ventures Drives Duchenne Muscular Dystrophy Research with $26 Million Investment
2年前
RYBREVANT® Plus Lazertinib Shows Significant PFS Improvement in EGFR-Mutated NSCLC
去年
MARIPOSA-2: Updated Data on Amivantamab Plus Chemotherapy in EGFR-Mutated NSCLC
12个月前
DEBRA Research and Nonsense Therapeutics Form ReadOn Therapeutics to Advance Epidermolysis Bullosa Treatments
去年
Amivantamab Plus Lazertinib Demonstrates Superior Overall Survival in EGFR-Mutated NSCLC
去年
DEBRA Research and Dermaliq Partner to Develop Touchless Drug Delivery for Epidermolysis Bullosa
8个月前
DEBRA Research and University Medical Center Groningen Launch Dedicated Clinical Trial Site for Epidermolysis Bullosa
2年前
Osimertinib and Amivantamab Gain FDA Approval for EGFR-Mutated NSCLC
9个月前
Updated Survival Data from FLAURA2 and MARIPOSA Trials Reshape Treatment Selection in EGFR-Mutated Advanced NSCLC
第 1 页,共 19 页
上一页
下一页